Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PaPa Trial: intravenous paracetamol as adjunct to remifentanil PCA during labor
NL-OMON49620Active, not recruiting
- Sponsor
- Reinier de Graaf Hospital
- Start
- Jun 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in labor pain comparing Paracetamol + remifentanil PCA with Placebo + remifentanil PCA (2 arms). Primary endpoints: Administered remifentanil doses after 60 minutes, Remifentanil bolus requests at 30, 60, 90, 120, 150, and 180 minutes and 1 more. Started Jun 2020; status: active, not recruiting.
02
Drugs
acetaminophenremifentanil
03
Conditions
labor pain
Beyond the preview
Go deeper on NL-OMON49620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49620.